Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 8, 2001, Pages 639-642

  Boyanovsky, B ^a,b   Russev, M ^a,c   Ganev, V ^a   Penev, M ^a   Baleva, M ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Deep vein thrombosis; Factor V Leiden; Prothrombin 20210 A; Pulmonary thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; BLOOD CLOTTING FACTOR 5;

ADULT; AGED; ARTICLE; BULGARIA; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; HETEROZYGOTE; MUTATION; PREVALENCE; RISK FACTOR; VEIN THROMBOSIS;

ADULT; AGED; BULGARIA; CASE-CONTROL STUDIES; COMPARATIVE STUDY; FACTOR V; FEMALE; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MALE; MIDDLE AGE; MUTATION; PREVALENCE; PROTHROMBIN; PULMONARY EMBOLISM; RISK FACTORS; VARIATION (GENETICS); VENOUS THROMBOSIS;

EID: 0035209652     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200112000-00004     Document Type: Article

References (21)

1. Familial thrombophilia due to a previously unrecognized mechanism recognized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
2. Factor V Leiden and thrombophilia
3. Resistance to activated protein C caused by the factor V R506Q mutation is a common risk factor for venous thrombosis
4. Inherited thrombophilia: Part I
5. Inherited thrombophilia: Part II
6. Mutation in blood coagulation factor V associated with resistance to activated protein C
7. 506 of factor V
8. Venous thrombosis due to activated protein C: Leiden thrombophilia study
9. A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
10. The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilia and is not increased in frequency in artery disease
11. A prothrombin gene mutation is significantly associated with venous thrombosis
12. Resistance to activated protein C in an unselected population of patients with pulmonary thromboembolism
13. Low Prevalence of factor V: 506 in 41 patients with isolated pulmonary thromboembolism
14. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism a focus on the factor V Leiden mutation
15. Relative risk of pulmonary embolism and deep venous thrombosis in association with factor V Leiden mutation in a UK population
16. Factor V Leiden mutation in women with idiopathic pulmonary embolism
17. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep venous thrombosis really different?
18. 506 → Gln mutation in factor V Leiden
19. A simple method for detection of factor V R506Q (Leiden) mutation in dried blood spots
20. Confidence intervals rather than P values: Estimation rather than hypothesis testing
21. The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis